The preliminary efficacy of KN026 (Anti-HER2 BsAb) in advanced gastric and gastroesophageal junction cancer patients with HER2 expression.

Jianming Xu,Yun Zhang,Jun Wu,Nong Xu,Jieer Ying,Xiaojun Xiang,Yanqiao Zhang,Jianhong Wang,Rusen Zhao,Feng Ye,Qiong Wu,Baohong Guo,Yuchen Liu,Juan Liu,Shuning Xing,Ting Xu

The preliminary efficacy of KN026 (Anti-HER2 BsAb) in advanced gastric and gastroesophageal junction cancer patients with HER2 expression.

2021

Jianming Xu
Yun Zhang
Jun Wu
Nong Xu
Jieer Ying
Xiaojun Xiang
Yanqiao Zhang
Jianhong Wang
Rusen Zhao
Feng Ye
Qiong Wu
Baohong Guo
Yuchen Liu
Juan Liu
Shuning Xing
Ting Xu

e16005Background: HER2 overexpression or amplification has been proven to be a validated therapeutic target for HER2-positive gastric and gastroesophageal junction cancer (GC/GEJ) in ToGA trial. Ho...

Keywords:

Gastroesophageal Junction
Medicine
Internal medicine
Oncology
Cancer
her2 expression
anti her2

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations